Panvac-VF; Panvac-V (inalimarev) plus Panvac-F (falimarev); vaccinia virus expressing carcinoembryonic antigen (CEA) and mucin-1 (MUC-1) tumor antigens, plus fowlpox virus expressing CEA and MUC-1, recombinant -- Product Record

Cancer vaccine, poxvirus vectors, rDNA

    Nomenclature:
      Cancer vaccine, poxvirus vectors, rDNA [BIO]
      Panvac-VF [TR]
      Panvac-F [TR for component]
      Panvac-V [TR for component]
      falimarev [SY for Panvac-F]
      inalimarev [SY for Panvac-V]
      rF-CEA(6D)-TRICOM [SY for Panvac-F]
      rV-CEA(6D)-TRICOM [SY for Panvac-V]
      vaccinia virus expressing carcinoembryonic antigen (CEA) and mucin-1 (MUC-1) tumor antigens, plus fowlpox virus expressing CEA and MUC-1, recombinant [SY]

    FDA Class:  Biologic BLA

Index Terms:

  • Product Class Index:
      BHK-21 (C-13)
      cancer treatment adverse effects
      potato medium, glycerinized
      recombinant DNA
      vaccines, intranasal
  • Biological Index:
      carcinoembryonic antigen (CEA)
      chicken embryo (egg) culture
      Costar cubes
      Fourth Intl. Standard (WHO 88/804) for Factor VIII
      MRC5 cellular proteins
      neutropenia
      potato medium, glycerinized
      tri-n-butyl phosphate (TNBP)
      vaccinia virus vaccine
      virus culture
      virus culture
  • Chemical Index:
  • Source/Host/Expression System: chicken embryo cell culture mampoulchiccells
  • Regulatory/Status Index:
      North American coral snake
      North American coral snake
      octoxynol (Triton X-100)
      Sp2/0 murine hybridoma/myeloma cells
      EU000 Not yet/Never filed with EU
      UM999 Not Available/Not Marketed in US
      US000 never filed/no plans
      EM999 Not Available/Not Marketed in EU